Cargando…
Combination of Vitamin C and Lenvatinib potentiates antitumor effects in hepatocellular carcinoma cells in vitro
Lenvatinib has become a first-line drug in the treatment of advanced hepatocellular carcinoma (HCC). Investigating its use in combination with other agents is of great significance to improve the sensitivity and durable response of Lenvatinib in advanced HCC patients. Vitamin C (L-ascorbic acid, asc...
Autores principales: | Wang, Xinyue, Qian, Songyi, Wang, Siyi, Jia, Sheng, Zheng, Nishang, Yao, Qing, Gao, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884045/ https://www.ncbi.nlm.nih.gov/pubmed/36718449 http://dx.doi.org/10.7717/peerj.14610 |
Ejemplares similares
-
Chelidonine enhances the antitumor effect of lenvatinib on hepatocellular carcinoma cells
por: Hou, Fang-jie, et al.
Publicado: (2019) -
Antitumor Effect of Lenvatinib Combined with Alisertib in Hepatocellular Carcinoma by Targeting the DNA Damage Pathway
por: Hao, Jianwen, et al.
Publicado: (2021) -
Comprehensive analysis of the correlations of S100B with hypoxia response and immune infiltration in hepatocellular carcinoma
por: Yan, Jia, et al.
Publicado: (2022) -
Synergistic antitumor efficacy of aspirin plus lenvatinib in hepatocellular carcinoma via regulating of diverse signaling pathways
por: Yan, Xijing, et al.
Publicado: (2023) -
Differential expression of lysine acetylation proteins in gastric cancer treated with a new antitumor agent bioactive peptide chelate selenium
por: Xu, Yanan, et al.
Publicado: (2023)